BioStem Technologies
Manufacturing · Florida, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
4901 NW 17th Way Ste 606, Fort Lauderdal...Phone Number
(954) 380-8342Website
www.biostemtechnologies.comRevenue
$292.2 MillionStock Symbol
BSEMIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About BioStem Technologies
BioStem Technologies, Inc. is a global life sciences corporation, providing innovative technologies with a concentration in Regenerative Medicine. The company's mission is to discover, develop and produce the most effective Regenerative Medicine products in the world. BioStem Technologies offers a comprehensive portfolio of high-quality brands that include RHEO, VENDAJE, VENDAJE AC, and VENDAJE OPTIC. The company is comprised of a diverse group of scientists, physicians, and entrepreneurs who collaborate to create innovative products.Explore more
BioStem Technologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioStem Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when BioStem Technologies launches new products
Funding: Get notified immidiatlly once BioStem Technologies has new funding data
Earning: See what the market has to say on BioStem Technologies recently announced quarterly report
Check if BioStem Technologies has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at BioStem Technologies
BioStem Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if BioStem Technologies is spiking on competitors!
Click to see if BioStem Technologies had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined BioStem Technologies as Masked Content
Find 2 more new buyers
Compare Similar Companies to BioStem Technologies
Compare insights from companies similar to BioStem Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BioStem Technologies is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BioStem Technologies is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BioStem Technologies.
BioStem Technologies financials insights
Gather financial insights about BioStem Technologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$146K
2026
Stock/Share Issuance
$2.5M
BioStem Technologies Tech Stack
A closer look at the technologies used by BioStem Technologies
Most Recent Scoops
Funding
Funding
New Hire
Executive Move
Executive Moves, New Hire
Hiring Plans
BioStem Technologies has more open roles in Operations than it has had at any time in the past 12 months. Technologies mentioned include: NetSuite ERP, NetSuite, and Route. Areas of expertise include: Administrative Support, and Calendar Management.
Hiring Plans
Open Position
Promotion
Executive Move
Executive Moves, Promotion
BioStem Technologies News & Media
BioStem Technologies Expands Board with Three Appointments as Nasdaq Uplisting Remains a Key Objective (BSEM)
The regenerative medicine company added experienced healthcare, biotech, and investment professionals to its board while highlighting governance and growth initiatives tied to its planned Nasdaq uplisting. Key Investor TakeawaysBioStem Technologies (USOTC:BSEM) appointed three new independent directors with backgrounds in biotechnology, healthcare leadership, and capital markets.BioStem Technologies Announces Appointment of Three New Members to its Board of Directors
BioStem Technologies Announces Appointment of Three New Members to its Board of DirectorsBioStem Technologies Secures $2.5 Million Investment in Private Placement Financing
BioStem Technologies recently announced a $2.5 million […]BioStem Technologies Announces $2.5 Million Private Placement Financing with its First Institutional Investor
BioStem Technologies Announces $2.5 Million Private Placement Financing with its First Institutional Investor
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioStem Technologies
Sign Up For FreeTo access detailed company insights
BioStem Technologies, Inc. is a global life sciences corporation, providing innovative technologies with a concentration in Regenerative Medicine. The company's mission is to discover, develop and produce the most effective Regenerative Medicine products in the world. BioStem Technologies offers a comprehensive portfolio of high-quality brands that... Read More
